CDC42 and colorectal carcinoma: In order to confirm the possible clinical relevance of CACNA2D2 and also its correlation with CDC42 in CRC, we validated our results in a independent third CRC cohort of 54 patients where we had previously analyzed CDC42 protein levels [8] (Table 1 and Figure 3B).